海金格医药是否真的陷入了危机？从最新的国家药监局飞检通报来看，这家新三板上市的CRO企业似乎正被推向风口浪尖。随着国内CRO市场规模预计在2023年突破1400亿元，海金格医药却在这样一个黄金赛道上面临重重挑战，究竟是怎么回事？
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback